Breaking News Instant updates and real-time market news.

KAR

KAR Auction

$54.17

(0.00%)

09:45
04/16/19
04/16
09:45
04/16/19
09:45

KAR Auction rises 3% after Starboard Value discloses stake

Starboard Value founder Jeffrey Smith disclosed at the 13D Monitor Active-Passive Summit that his activist investment firm has taken a new position in KAR Auction Services, according to Reuters. "We believe KAR is a tremendous opportunity," Smith was quoted as having said, adding that he thinks portions of the business can be spun off in the near term, according to the report. In early trading, KAR Auction shares are up $1.72, or 3.2%, to $55.87. Reference Link

  • 23

    May

  • 03

    Jun

  • 13

    Nov

KAR KAR Auction
$54.17

(0.00%)

09/21/18
JPMS
09/21/18
DOWNGRADE
Target $47
JPMS
Underweight
Copart downgraded to Underweight from Neutral at JPMorgan
JPMorgan analyst Ryan Brinkman downgraded Copart (CPRT) to Underweight and lowered his price target for the shares to $47 from $48. The company reported softer than expected Q4 results this week but trades at "near record multiples" of earnings and EBITDA, Brinkman tells investors in a research note. The analyst sees a potential pair trade in going long KAR Auction (KAR) shares, and short Copart shares, to capitalize on the "valuation disconnect."
09/21/18
09/21/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. UBS SAYS BUY AT&T: UBS analyst John Hodulik upgraded AT&T (T) to Buy and raised his price target for the shares to $38 from $33, noting that the stock is trading near all-time low valuations and at its widest valuation gap to Verizon (VZ). The Time Warner transaction and accounting changes "have compounded [other] issues, leading to a loss of visibility for investors," but his work indicates that AT&T will return to EBITDA growth in the second half of 2018, after a 6% decline in the first half, due to growth in Wireless and WarnerMedia as well as slower declines in Entertainment. JPMORGAN GOES TO BULL FROM BEAR ON NOVAVAX: JPMorgan analyst Eric Joseph double upgraded Novavax (NVAX) to Overweight from Underweight saying the risk/reward is favorable into the report of Prepare trial data in Q1 of 2019. The trial is assessing the efficacy of the company's RSV F Vaccine for infants via maternal immunization and the analyst believes the shares can hit a range of $2.00 to $2.25, he told investors. JPMORGAN SUGGESTS BEING SHORT COPART, LONG KAR: JPMorgan analyst Ryan Brinkman downgraded Copart (CPRT) to Underweight and lowered his price target for the shares to $47 from $48. The company reported softer than expected Q4 results this week but trades at "near record multiples" of earnings and EBITDA, Brinkman told investors. The analyst sees a potential pair trade in going long KAR Auction (KAR) shares, and short Copart shares, to capitalize on the "valuation disconnect." LOOP SETS $8.25 TARGET ON HARMONIC: Loop Capital analyst James Kisner initiated Harmonic (HLIT) with a Buy rating and $8.25 price target, saying he believes Harmonic can "drive robust revenue growth on its Cable Edge business as cable operators like Comcast (CMCSA, CMCSK) adopt its virtual CCAP/CMTS solution," and that the company's video business with stabilize. 'DON'T PANIC' OVER DOD PROPOSAL: Morgan Stanley analyst Rajeev Lalwani attributes the underperformance in Defense stocks over the last two days compared to the broader market to heightened concerns around a month old proposal from the Department of Defense to adjust progress and performance payments down to 50% from 80% of cost, which would effectively slow the timing of cash flow receipts closer to when a project is complete. He sees a number of reasons not to panic, mainly because he believes that the Administration will not move forward with a proposal industry-players will paint as being anti-business and anti-defense spending. Publicly-traded defense contractors include General Dynamics (GD), Huntington Ingalls (HII), L3 Technologies (LLL), Lockheed Martin (LMT), Northrop Grumman (NOC) and Raytheon (RTN).
01/07/19
RHCO
01/07/19
NO CHANGE
Target $65
RHCO
Buy
KAR Auction price target lowered to $65 from $70 at SunTrust
SunTrust analyst Stephanie Benjamin lowered her price target on KAR Auction to $65 as part of her broader research note on the Auto Services companies. The analyst believes that the company may not see "similar levels of higher revenue-per -unit catastrophic vehicles sold" in Q4 relative to last year, adding that her new price target reflects her expectation of multiple compression. Longer term, Benjamin keeps her Buy rating on KAR Auction, anticipating the spinout of its salvage business to drive multiple expansion.
02/21/19
SPIN
02/21/19
UPGRADE
SPIN
Buy
KAR Auction upgraded to Buy from Hold at Spin-Off Research

TODAY'S FREE FLY STORIES

NMCI

Navios Maritime Containers

$2.24

(0.00%)

07:58
04/25/19
04/25
07:58
04/25/19
07:58
Hot Stocks
Navios Maritime Containers announces delivery of one containership »

Navios Maritime…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LRCX

Lam Research

$195.40

0.56 (0.29%)

07:56
04/25/19
04/25
07:56
04/25/19
07:56
Recommendations
Lam Research analyst commentary at Citi »

Citi ups target on top…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

TSLA

Tesla

$258.70

-5.15 (-1.95%)

07:55
04/25/19
04/25
07:55
04/25/19
07:55
Downgrade
Tesla rating change  »

Tesla downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSFT

Microsoft

$125.00

-0.5 (-0.40%)

07:55
04/25/19
04/25
07:55
04/25/19
07:55
Recommendations
Microsoft analyst commentary at BMO Capital »

Microsoft price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 03

    Jun

  • 03

    Jun

  • 08

    Jun

  • 10

    Jun

  • 23

    Jun

  • 06

    Aug

VBIV

VBI Vaccines

$2.00

(0.00%)

07:55
04/25/19
04/25
07:55
04/25/19
07:55
Conference/Events
VBI Vaccines to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 10

    May

  • 23

    May

UBSI

United Bankshares

$38.81

0.03 (0.08%)

07:53
04/25/19
04/25
07:53
04/25/19
07:53
Earnings
United Bankshares reports Q1 EPS 62c, consensus 61c »

Reports Q1 book value per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 15

    May

HBAN

Huntington Bancshares

$13.75

-0.04 (-0.29%)

07:53
04/25/19
04/25
07:53
04/25/19
07:53
Hot Stocks
Huntington Bancshares reaffirms three-year target of 4%-6% revenue growth »

For 2019, sees FY19…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 30

    May

  • 31

    May

  • 29

    Aug

APC

Anadarko

$71.41

7.29 (11.37%)

, OXY

Occidental Petroleum

$62.00

-0.35 (-0.56%)

07:52
04/25/19
04/25
07:52
04/25/19
07:52
Downgrade
Anadarko, Occidental Petroleum, Chevron rating change at Jefferies »

Jefferies downgrades…

APC

Anadarko

$71.41

7.29 (11.37%)

OXY

Occidental Petroleum

$62.00

-0.35 (-0.56%)

CVX

Chevron

$118.31

-3.69 (-3.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 28

    Apr

  • 30

    Apr

  • 07

    May

  • 10

    May

  • 14

    May

  • 22

    May

  • 29

    May

MTSI

Macom

$15.86

-0.33 (-2.04%)

07:51
04/25/19
04/25
07:51
04/25/19
07:51
Downgrade
Macom rating change  »

Macom downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

ABBV

AbbVie

$78.71

0.06 (0.08%)

07:49
04/25/19
04/25
07:49
04/25/19
07:49
Hot Stocks
AbbVie reports Q1 global hematologic oncology portfolio revenue $1.173B »

Global net revenues from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 28

    Apr

  • 03

    May

  • 03

    May

  • 04

    May

  • 18

    May

  • 31

    May

  • 05

    Jun

APC

Anadarko

$71.41

7.29 (11.37%)

, OXY

Occidental Petroleum

$62.00

-0.35 (-0.56%)

07:48
04/25/19
04/25
07:48
04/25/19
07:48
Recommendations
Anadarko, Occidental Petroleum, Chevron analyst commentary at Morgan Stanley »

Strategic value of…

APC

Anadarko

$71.41

7.29 (11.37%)

OXY

Occidental Petroleum

$62.00

-0.35 (-0.56%)

CVX

Chevron

$118.31

-3.69 (-3.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 28

    Apr

  • 30

    Apr

  • 07

    May

  • 10

    May

  • 14

    May

  • 22

    May

  • 29

    May

PTC

PTC

$101.94

1.12 (1.11%)

07:48
04/25/19
04/25
07:48
04/25/19
07:48
Downgrade
PTC rating change  »

PTC downgraded to Neutral…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NXGN

NextGen Healthcare

$17.65

0.38 (2.20%)

07:47
04/25/19
04/25
07:47
04/25/19
07:47
Upgrade
NextGen Healthcare rating change  »

NextGen Healthcare…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

ABBV

AbbVie

$78.71

0.06 (0.08%)

07:47
04/25/19
04/25
07:47
04/25/19
07:47
Hot Stocks
AbbVie CEO says 'we are off to another excellent start' »

"We are off to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 28

    Apr

  • 03

    May

  • 03

    May

  • 04

    May

  • 18

    May

  • 31

    May

  • 05

    Jun

ABBV

AbbVie

$78.71

0.06 (0.08%)

07:46
04/25/19
04/25
07:46
04/25/19
07:46
Hot Stocks
AbbVie reports Q1 U.S. HUMIRA sales of $3.215B up 7.1% »

IInternationally, HUMIRA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 28

    Apr

  • 03

    May

  • 03

    May

  • 04

    May

  • 18

    May

  • 31

    May

  • 05

    Jun

AZPN

Aspen Technology

$114.55

2.435 (2.17%)

07:45
04/25/19
04/25
07:45
04/25/19
07:45
Upgrade
Aspen Technology rating change  »

Aspen Technology upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

07:45
04/25/19
04/25
07:45
04/25/19
07:45
General news
Treasury Market Outlook: bond markets are mixed »

Treasury Market Outlook:…

XLNX

Xilinx

$139.79

2.66 (1.94%)

07:44
04/25/19
04/25
07:44
04/25/19
07:44
Downgrade
Xilinx rating change at Needham »

Xilinx downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    May

CIGI

Colliers International

$69.14

-0.39 (-0.56%)

07:44
04/25/19
04/25
07:44
04/25/19
07:44
Hot Stocks
Colliers International acquires affiliate in Sweden »

Colliers International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 05

    Jun

ABBV

AbbVie

$78.71

0.06 (0.08%)

07:43
04/25/19
04/25
07:43
04/25/19
07:43
Earnings
AbbVie raises FY19 adj. EPS view to $8.73-$8.83 from $8.65-$8.75 »

FY19 consensus $8.69. The…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 28

    Apr

  • 03

    May

  • 03

    May

  • 04

    May

  • 18

    May

  • 31

    May

  • 05

    Jun

HAS

Hasbro

$103.18

2.84 (2.83%)

07:42
04/25/19
04/25
07:42
04/25/19
07:42
Downgrade
Hasbro rating change at Argus »

Hasbro downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    May

  • 29

    May

WAB

Wabtec

$76.57

-0.19 (-0.25%)

, GE

General Electric

$9.32

-0.025 (-0.27%)

07:42
04/25/19
04/25
07:42
04/25/19
07:42
Hot Stocks
Wabtec CEO Ray Betler to retire, Rafael Santana to succeed »

Wabtec (WAB) announced…

WAB

Wabtec

$76.57

-0.19 (-0.25%)

GE

General Electric

$9.32

-0.025 (-0.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 30

    Apr

  • 08

    May

  • 08

    May

  • 21

    May

  • 29

    May

  • 05

    Jun

  • 05

    Jun

  • 13

    Nov

ABBV

AbbVie

$78.71

0.06 (0.08%)

07:42
04/25/19
04/25
07:42
04/25/19
07:42
Hot Stocks
Breaking Hot Stocks news story on AbbVie »

AbbVie raises FY19…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 28

    Apr

  • 03

    May

  • 03

    May

  • 04

    May

  • 18

    May

  • 31

    May

  • 05

    Jun

ABBV

AbbVie

$78.71

0.06 (0.08%)

07:42
04/25/19
04/25
07:42
04/25/19
07:42
Earnings
AbbVie reports Q1 adjusted EPS $2.14, consensus $2.06 »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 28

    Apr

  • 03

    May

  • 03

    May

  • 04

    May

  • 18

    May

  • 31

    May

  • 05

    Jun

HBAN

Huntington Bancshares

$13.75

-0.04 (-0.29%)

07:40
04/25/19
04/25
07:40
04/25/19
07:40
Earnings
Huntington Bancshares sees FY19 revenue up 4%-7%, consensus $4.76B »

The company said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 30

    May

  • 31

    May

  • 29

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.